Pasar al contenido principal

BEGIN: FENOMICA Y METODOS DE APRENDIZAJE AUTOMATICO COMBINADOS PARA MEJORAR EL DIAGNOSTICO DE LOS TRASTORNOS PSICOTICOS

PID2020-113609RB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population

  • Echeverry-Quiceno, L.M.|||0000-0002-9799-0252
  • Llambrich, S.|||0000-0001-9980-0208
  • Heredia-Lidón, None|||0000-0001-6325-8744
  • Giménez, Sandra|||0000-0001-8031-2319
  • Aranha, Mateus|||0000-0001-9594-292X
  • Inampudi, P.
  • Heuzé, Y.|||0000-0002-0660-9613
  • Sevillano, X.|||0000-0002-6209-3033
  • Fortea, Juan|||0000-0002-1340-638X
  • Martínez-Abadías, N.|||0000-0003-3061-2123
Down syndrome (DS), caused by trisomy 21, is associated with an increased risk of Alzheimer's disease (AD) and obstructive sleep apnea (OSA). Traditional diagnostic methods for AD and OSA, like cerebrospinal fluid analysis and polysomnography, are invasive and challenging for people with DS. In this study, we assessed whether facial morphology could be used as a potential noninvasive biomarker for these conditions in both DS and the general population. We performed a comprehensive 3D analysis of facial shape variation by registering the 3D coordinates of 21 landmarks on facial models extracted from magnetic resonance images of 131 individuals with DS and 216 euploid (EU) adult controls, including AD and OSA cases. Procrustes ANOVA and MANOVA quantified shape variation by sex, age, and facial size, while geometric morphometrics assessed diagnostic group differences. Significant facial shape differences were observed between the DS and EU groups, indicating sex-dependent differences and altered age-related changes in DS, particularly in females. Facial shape correlated with the amyloid beta ratio (Aβ1-42/Aβ1-40), a key AD biomarker. In DS, facial shape differences by AD diagnosis were not significant after adjusting for age and facial size, but significant shape differences were detected in the EU population. For OSA, facial shape correlated with the apnea-hypopnea index (AHI), and DS individuals with severe OSA showed distinct facial morphology compared with those without OSA, suggesting an association between facial shape and sleep respiratory disturbances. These results highlight the potential of facial morphology as a noninvasive biomarker for AD and OSA detection and management.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BioFace3D, An end-to-end open-source software for automated extraction of potential 3D facial biomarkers from MRI scans

  • Heredia-Lidón, None|||0000-0001-6325-8744
  • Echeverry-Quiceno, L.M.|||0000-0002-9799-0252
  • González, Alejandro
  • Hostalet, Noemí
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Fortea, Juan|||0000-0002-1340-638X
  • Fatjó-Vilas, Mar|||0000-0001-9963-6241
  • Martínez-Abadías, N.|||0000-0003-3061-2123
  • Sevillano, X.|||0000-0002-6209-3033
Background and Objectives: Facial dysmorphologies have emerged as potential critical indicators in the diagnosis and prognosis of genetic, psychotic, and rare disorders. While some conditions present with severe dysmorphologies, others exhibit subtler traits that may not be perceivable to the human eye, requiring the use of precise quantitative tools for accurate identification. Manual annotation remains time-consuming and prone to inter- and intra-observer variability. Existing tools provide partial solutions, but no end-to-end automated pipeline integrates the full process of 3D facial biomarker extraction from magnetic resonance imaging. Methods and Results: We introduce BioFace3D, an open-source pipeline designed to automate the discovery of potential 3D facial biomarkers from magnetic resonance imaging. BioFace3D consists of three automated modules: (i) 3D facial model extraction from magnetic resonance images, (ii) deep learning-based registration of homologous anatomical landmarks, and (iii) computation of geometric morphometric biomarkers from landmark coordinates. Conclusions: The evaluation of BioFace3D is performed both at a global level and within each individual module, through a series of exhaustive experiments using proprietary and public datasets, demonstrating the robustness and reliability of the results obtained by the tool. Source code, along with trained models, can be found at https://bitbucket.org/cv_her_lasalle/bioface3d.